Histologic Subtypes of Renal Cell Carcinoma



Similar documents
Histopathology and prognosis in renal cancer

New Concepts and Refinements to. Existing WHO (2004) Renal Cell. Tumor Categories In Adults

SEMESTER VI 3 RD YEAR PATHOLOGY KIDNEY TUMORS

RENAL CANCER PATHOLOGY WHAT REALLY MATTERS? STEWART FLEMING UNIVERSITY OF DUNDEE

Emerging Subtypes in Renal Cancer. Donna E. Hansel, MD PhD Professor of Pathology, UC San Diego Division Chief, Anatomic Pathology

Something Old, Something New.

Epithelial Tumors of the Kidney Diagnostic Problems and Recently Described Entities

Renal Cell Carcinoma: Advances in Diagnosis B. Iványi, MD

Renal Pathology Update. Sundus Hussein MD, FRCPC

The WHO Classification of Renal Tumors and Common Issues in TNM Staging for Renal Cell Carcinoma

RENAL CELL CARCINOMA EPIDEMIOLOGY

Renal Tumors with Eosinophilic Cytoplasm: 2013 Classification. Jesse K. McKenney, MD Associate Head, Surgical Pathology

The Mainz Classification of Renal Cell Tumors

CT and MRI features of the Pathologic Subtypes of Papillary Renal Cell Carcinoma. Melissa Price, MD Aoife Kilcoyne, MD Mukesh G.

2009 update on the classification of renal epithelial tumors in adults

Tubulocystic Carcinoma of the Kidney, a Rare Distinct Entity

Successes and Limitations of Targeted Therapies in Renal Cell Carcinoma

Pathology of Renal Cell Carcinoma

Gladwyn Leiman, MCCCh, FIAC, FRCPath Scott Anderson, MD

Role of histopatological assessment of renal cancer specimen after radical and partial nephrectomy

Outcome prediction for renal cell carcinoma (RCC)

Renal Neoplasms: An Update on Immunohistochemical and Histochemical Features

Classificazione anatomo-patologica nei RCC Matteo Brunelli. Department of Pathology and Diagnostic, University di Verona, Italy

Translocation Renal Cell Carcinomas

Emerging and Newly Recognized Subtypes of Renal Tumors: Keys to Recognition Session 1006

Seattle. Case Presentations. Case year old female with a history of breast cancer 12 years ago. Now presents with a pleural effusion.

CHAPTER CHROMOPHILIC RENAL CELL CANCER

KIDNEY CARCINOMA ASSOCIATED WITH XP11.2 TRANSLOCATION / TFE3 (ASPL-TFE3) GENE FUSION

Kidney Cancer OVERVIEW

NEOPLASMS OF KIDNEY (RENAL CELL CARCINOMA) And RENAL PELVIS (TRANSITIONAL CELL CARCINOMA)

Histopathology of Major Salivary Gland Neoplasms

Carcinoma papilar renal, cromófobo y otras histologías. Maria José Méndez Vidal Servicio de oncología Medica Hospital Reina Sofía Córdoba

Medullary Renal Cell Carcinoma Case Report

CASE REVIEW. Oncocytic Renal Neoplasms. A Molecular Approach to a Common Diagnostic Challenge

Molecular Pathogenesis of Renal Cell Carcinoma: A Review

The role of Immunohistochemistry in diagnosis of renal cell carcinoma subtypes.

Protocol for the Examination of Specimens From Patients With Invasive Carcinoma of Renal Tubular Origin

Four Important Facts about Kidney Cancer

From Immunotherapy of Cancer to the Discovery of Kidney Cancer Genes

Kidney Cancer (Adult) - Renal Cell Carcinoma What is cancer?

RENAL EPITHELIAL TUMORS 2009: THE ROLE OF ELECTRON MICROSCOPY IN UNDERSTANDING PATHOGENESIS, DIAGNOSIS, AND CLASSIFICATION.

Molecular Diagnostics in Thyroid Cancer

TUMORS OF THE TESTICULAR ADNEXA and SPERMATIC CORD

MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY

MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY

RENAL PARENCHYMAL MALIGNANCY (RENAL CELL CARCINOMA) STRUCTURED REPORTING PROTOCOL. (1st EDITION 2011)

Malignant Lymphomas and Plasma Cell Myeloma

The evolving pathology of solitary fibrous tumours. Luciane Dreher Irion MREH / CMFT / NSOPS

Multiple Primary and Histology Site Specific Coding Rules KIDNEY. FLORIDA CANCER DATA SYSTEM MPH Kidney Site Specific Coding Rules

Targeted Molecular Therapy for Renal Cell Carcinoma: Impact on Existing Treatment Paradigms

DESMOPLASTIC SMALL ROUND CELL TUMOR: A RARE PATHOLOGY PUZZLE

The Role of Genetic Testing in the Evaluation of Thyroid Nodules. Thyroid Cancer and FNA. Thyroid Cancer. Pure Follicular Cancers.

BRAF as a prognostic marker in papillary thyroid cancer

Renal Cell Carcinoma Associated with Xp11.2 Translocation: Clinicopathologic and Immunohistochemical Findings of 4 Cases

Immunohistochemical Analysis of Chromophobe Renal Cell Carcinoma, Renal Oncocytoma, and Clear Cell Carcinoma

PRIMARY SEROUS CARCINOMA OF PERITONEUM: A CASE REPORT

Update on Mesothelioma

CHAPTER 1. Tumours of the Kidney

Mature Lymphoproliferative disorders (2): Mature B-cell Neoplasms. Dr. Douaa Mohammed Sayed

Translocation Renal Cell Carcinomas: Molecular insights and Future Directions

Common Cancers & Hereditary Syndromes

A912: Kidney, Renal cell carcinoma

VHL and clear cell Renal Cell Carcinoma. Expression profiling reveals cell of origin. Renal Cell Carcinoma (RCC) Title. VHL syndrome hallmark cancer:

Introduction to Pathology and Diagnostic Medicine

PathMD: Board Review Letter TM

Keywords pediatric renal cell carcinoma, TFE3, Xp11.2 translocation carcinomas, prognosis

GENETIC TESTING FOR INHERITED MUTATIONS OR SUSCEPTIBILITY TO CANCER OR OTHER CONDITIONS MED

Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Interesting Case Review. Renuka Agrawal, MD Dept. of Pathology City of Hope National Medical Center Duarte, CA

Introduction. Wu A, Kunju L P, Cheng L & Shah R B (2008) Histopathology 53,

What is Cancer? Cancer is a genetic disease: Cancer typically involves a change in gene expression/function:

Thyroid Differentiated Cancer: Does Size Really Count? (New ways to evaluate thyroid nodules)

A disease of populations of cells that live, divide, invade and spread without regard to normal limits

Transcription:

Histologic Subtypes of Renal Cell Carcinoma M. Scott Lucia, MD Associate Professor Chief of Genitourinary and Renal Pathology Director, Prostate Diagnostic Laboratory Dept. of Pathology University of Colorado Denver SOM History of Classification of Renal Cell Neoplasms First case in literature reported by G. Miriel in 1810 First classication in 1826, proposed by König, on basis of gross morphologic appearance into four types: Fungoid, Medullary, Scirrhous, Steatomatous Many subsequent classifications many based upon descriptive histologic features of tumors (archetectural and cytologic) Mainz classification proposed by Thoenes 1986 based upon cytologic features of tumors first to correlate the subtypes of tumors with cell of origin in nephron Delahunt B. Eble JN. History of the development of the classification of renal cell neoplasia. Clinics in Laboratory Medicine. 2005;25:231-46. The Mainz Classification 1986 From: Delahunt B. Eble JN. Clinics in Laboratory Medicine. 2005;25:231-46. 2005 Elsevier Inc. 3.1

Studies have confirmed cytogenetic differences between major tumor subtypes in Mainz classification Tumor type Freq Histopathology Cytogenetics Clear cell RCC 70% -Clear cytoplasm -Alveolar, tubular and cystic architecture -Vascular stroma Chromophil RCC 15% -Papillary architecture -basophilic, low N:C (type I) -eosinophilic, high N:C (type II) Chromophobe RCC Collecting duct Carcinoma 5% -Solid architecture -Pale or granular cytoplasm -Prominent cell membranes -Occ. Bizarre nuclei 1-2% -Medullary location -Tubuloglandular architecture -Hobnail cells -Desmoplastic stroma -3p, +5q, -6q, -8p, -14q Trisomy 7, 17, -Y, +3q -1, -2, -6, -10, -13, -17, -21-1q, -6p, -8p, - 13q, -21q Heidelberg Classification 1997 1 Expanded on Mainz classification; based upon cytogenetics Clear cell conventional RCC Papillary RCC to replace Chromophil Collecting duct carcinoma Medullary carcinoma associated with sickle cell trait 1. Kovacs et al. J Pathol 1997;183:131-3. Clear Cell Renal Cell Carcinoma (20X) Clear Cell Renal Cell Carcinoma with necrosis 3.2

Fuhrman grading predictive of outcome Fuhrman grade II Fuhrman grade IV Clear Cell RCC - Cytogenetics Abnormalities involving VHL gene (3p25.3) (tumorsuppressor gene): Deletion (3p-) Translocation (3;6, 3;8, 3;11) Somatic mutation or hypermethylation (80% RCC) In both sporadic (95%) and familial (4%) RCC Familial, associated with VHL (Von Hippel-Lindau) syndrome: Hemangioblastomas of the cerebellum and retina Bilateral renal cysts Multiple RCCs (nearly all, if they survive older age) VHL Gene VHL protein part of ubiquitin ligase complex Degrades hypoxia-inducible factor (HIF-1) Degrades insulin-like growth factor-1 (IGF-1) Loss/ mutation results in: High levels of HIF-1 (stimulates angiogenesis via VEGF and TGF-b) Upregulation of IGF-1 (stimulates cells growth) Papillary RCC Basophilic (Type I) Eosinophilic (Type II) 3.3

Papillary RCC Hereditary and sporadic forms Hereditary usually multifocal and bilateral Most common cytogenetic abnormalities: Trisomy 7, 17 (hereditary and sporadic forms) Loss of Y in male patients (sporadic form) Protooncogene locus on chromosome 7 (cmet): Tyrosine kinase receptor for HGF Mutated in some sporadic cases Chromophobe renal cell carcinoma 5% of RCC Gross appearance: Solid tumor Mimics oncocytoma Derived from intercalated cell of collecting duct Numerous mitochondria and mitochronria-derived cytoplasmic vesicles Chromophobe renal cell carcinoma Fuhrman grading not reliable Prominent cell membranes Bizarre atypical nuclei Chromophobe RCC Eosinophilic variant CD117 Expression 3.4

A B C D A. Chromophobe RCC C. Oncocytoma B. Chromophobe RCC Colloidal iron D. Oncocytoma Colloidal iron Cancer-specific survival among clear cell, papillary and chromophobe RCC Overall Stage pt3 Cheville, J. et al. Amer J Surg Pathol 2003;27:612-624 Copyright 2009 Wolters Kluwer. Carcinoma of the Collecting Ducts of Bellini (Collecting Duct Carcinoma) Centrally located Medullary origin Derived from principal cell of collecting duct Usually present in advanced stage and higher grade Medullary carcinoma Aggressive variant of CDC that occurs in young black males with sickle cell trait 2004 World Health Organization Classification of Renal Cell Tumors Expanded on Mainz and Heidelberg classifications to account for cytogenetics, behavior, and associated conditions Clear cell RCC Multi-locular clear cell RCC (VHL gene mutation, good prognosis) Papillary RCC (Type I=basophilic, good prognosis; type II=eosinophilic, worse prognosis) Carcinoma of the collecting ducts of Bellini Renal medullary carcinoma Xp11 translocation carcinoma Carcinoma associated with neuroblastoma Mucinous, tubular, and spindle cell carcinoma Renal cell carcinoma, unclassified Papillary adenoma Oncocytoma 3.5

2004 World Health Organization Classification of Renal Cell Tumors Expanded on Mainz and Heidelberg classifications to account for cytogenetics, behavior, and associated conditions Clear cell RCC Multi-locular clear cell RCC (VHL gene mutation, good prognosis) Papillary RCC (Type I=basophilic, good prognosis; type II=eosinophilic, worse prognosis) Carcinoma of the collecting ducts of Bellini Renal medullary carcinoma Xp11 translocation carcinoma Carcinoma associated with neuroblastoma Mucinous, tubular, and spindle cell carcinoma Renal cell carcinoma, unclassified Papillary adenoma Oncocytoma Multilocular cystic renal cell carcinoma Good prognosis Most low grade (Fuhrman I or II) Usually stage I or II Mets not reported VHL mutations 2004 World Health Organization Classification of Renal Cell Tumors Expanded on Mainz and Heidelberg classifications to account for cytogenetics, behavior, and associated conditions Clear cell RCC Multi-locular clear cell RCC (VHL gene mutation, good prognosis) Papillary RCC (Type I=basophilic, good prognosis; type II=eosinophilic, worse prognosis) Carcinoma of the collecting ducts of Bellini Renal medullary carcinoma Xp11 translocation carcinoma Carcinoma associated with neuroblastoma Mucinous, tubular, and spindle cell carcinoma Renal cell carcinoma, unclassified (5% of RCC) Papillary adenoma Oncocytoma Conclusions The classification of renal cell carcinomas is expanding Classification has morphological and cytogenetic basis Proper classification important for prognosis 3.6